Alopecia areata (AA) is an immune-mediated disorder increasingly recognised for its systemic metabolic associations. Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome, shares common inflammatory and metabolic pathways with AA. However, the association between AA and NAFLD remains under-explored.
ChuSYChenYJTsengWC, et al.Comorbidity profiles among patients with alopecia areata: the importance of cardiovascular screening. J Am Acad Dermatol2015; 72: 613–620.
2.
PetukhovaLDuvicMHordinskyM, et al.Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature2010; 466: 113–117.
3.
McElweeKJGilharATobinDJ, et al.What causes alopecia areata?Exp Dermatol2013; 22: 609–626.
4.
BarahmaniNSchabathMBDuvicM, et al.History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol2009; 61: 581–591.
5.
YounossiZMKoenigABAbdelatifD, et al.Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology2016; 64: 73–84.
6.
ChalasaniNYounossiZLavineJE, et al.The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology2018; 67: 328–357.
7.
TargherGDayCPBonoraE. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med2010; 363: 1341–1350.
8.
GisondiPFostiniACFossàI, et al.Psoriasis and the metabolic syndrome. Clin Dermatol2018; 36: 21–28.
9.
SabatRJemecGBEMatusiakŁ, et al.Hidradenitis suppurativa. Nat Rev Dis Primers2020; 6: 18.
10.
OlsenEAHordinskyMKPriceVH, et al.Alopecia areata investigational assessment guidelines—part II. J Am Acad Dermatol2004; 51: 440–447.
11.
European Association for the Study of the Liver (EASL). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol2016; 64: 1388–1402.
12.
HuangKPJoyceCJTopazM, et al.Cardiovascular risk factors in patients with alopecia areata: a case-control study. Br J Dermatol2016; 174: 848–850.
13.
DakhilAS. Metabolic syndrome in patients with alopecia areata: a case-control study. J Pak Assoc Dermatol2021; 31: 322–327.
14.
ConicRZChuSTamashunasNL, et al.Prevalence of metabolic syndrome in patients with alopecia areata: a case-control study. Int J Dermatol2020; 59: e242–e244.
